(Q38782738)

6 September 2017

title

Cetuximab treatment alters the content of extracellular vesicles released from tumor cells (English)

1 reference

6 September 2017

1 reference

extracellular vesicle

1 reference

Roy van der Meel

2

0 references

Pieter Vader

object named as

Pieter Vader

5

0 references

Raymond M. Schiffelers

object named as

Raymond M Schiffelers

6

0 references

Wouter Van Solinge

object named as

Wouter W van Solinge

3

0 references

author name string

Susan M van Dommelen

1

1 reference

6 September 2017

Maria Coimbra

4

1 reference

6 September 2017

publication date

16 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

11

1 reference

6 September 2017

issue

8

1 reference

6 September 2017

page(s)

881-890

1 reference

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Different antiproliferative effects of matuzumab and cetuximab in A431 cells are associated with persistent activity of the MAPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Extracellular vesicles: emerging targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Taxol(®)-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor(®) EL.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM-2015-0009

21 January 2018

Identifiers

DOI

10.2217/NNM-2015-0009

1 reference

6 September 2017

1 reference